Mark Ratain News Today

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin

FDA urges drug companies to reassess cancer drug dosages for maximum impact and fewer side effects, following study on lung cancer drug

The main cause of the cancer drug shortage, experts agree, is the underlying weakness of the generic drug industry.

The main cause of the cancer drug shortage, experts agree, is the underlying weakness of the generic drug industry.

A shortage of low-cost generic drugs is posing serious health risks to cancer patients, and more generic manufacturers are struggling financially.

On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of

On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredded documents tossed into a

A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.

A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.

Doctors and their patients are facing the unimaginable: They are being forced into grim contemplation of untested rationing plans for breast, cervical, bladder, ovarian, lung, and other cancers.